Empty Capsules Market - Forecast to 2023: Development of Halal Gelatin Capsules & Rising Focus on Sports Nutrition


Dublin, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The "Empty Capsules Market by Type, Functionality, Application, End User - Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD 1.95 billion in 2018, at a CAGR of 7.4%.

The growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies are the major factors driving the market for empty capsules.

Emerging markets (due to their low manufacturing costs) are expected to present significant opportunities for players. Other areas of opportunity are the development of halal gelatin capsules and the rising focus on sports nutrition. However, cultural practices and dietary restrictions are expected to restrain the growth of the empty capsules market.

"The Non-gelatin Capsules Segment to Register the Highest CAGR During the Forecast Period."

By type, the empty capsules market is segmented into gelatin and non-gelatin capsules. The gelatin capsules segment is further subsegmented into pig meat gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules segment is further divided into hydroxypropyl methylcellulose (HPMC) and pullulan & starch material.

The non-gelatin capsules segment is expected to register the highest CAGR during the forecast period. This growth is largely driven by the increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, such as low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content.

"Immediate-release Capsules Are Projected to Register the Highest Growth Rate Between 2018 & 2023."

By functionality, the empty capsules market is segmented into immediate-release, sustained-release, and delayed-release capsules. The immediate-release capsules segment is expected to witness the highest CAGR in the empty capsules market during the forecast period, owing to the widespread use of these capsules for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements. Moreover, these capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.

"Dietary Supplements to Witness the Highest Growth Rate in the Forecast Period."

By application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other applications. The dietary supplements segment is expected to witness the highest CAGR during the forecast period. Factors such as increased health awareness and rising affordability in emerging countries (such as India, China, and Brazil), increasing prevalence of lifestyle diseases, and increasing use of vitamin capsules due to their availability as over-the-counter (OTC) drugs are contributing to the growth of this segment.

"Nutraceutical Industry to Be the Fastest-growing End-user Segment During the Forecast Period."

Based on end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The nutraceutical industry segment is expected to witness the highest CAGR during the forecast period. The rising demand for nutraceutical products to prevent the occurrence of lifestyle-associated diseases (such as obesity, arthritis, high blood pressure, cholesterol, and diabetes) is supporting the growth of this segment.

"APAC to Witness the Highest Growth in the Empty Capsules Market During the Forecast Period."

The empty capsules market in the APAC is expected to witness the highest CAGR during the forecast period. The presence of many global capsule manufacturers in China and India, growth in the pharmaceutical and nutraceutical industries, the relatively less stringent regulations in the nutraceutical industry in this region, an increasing focus on generics, and rising healthcare awareness are expected to drive the adoption of empty capsules in the Asia Pacific.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Empty Capsules: Market Overview
4.2 Market: Geographic Growth Opportunities
4.3 Regional Mix: Market (2018-2023)
4.4 Market: Developed vs Developing Markets, 2018 vs 2023

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Geriatric Population
5.2.1.2 Growth of the Pharmaceutical Market, Along With Increasing R&D Activities and Clinical Trials
5.2.1.3 Advancements in Capsule Delivery Technologies
5.2.2 Market Restraints
5.2.2.1 Cultural Practices and Dietary Restrictions
5.2.3 Market Opportunities
5.2.3.1 Emerging Countries
5.2.3.2 Development of Halal Gelatin Capsules
5.2.3.3 Rising Focus on Sports Nutrition
5.2.4 Market Challenges
5.2.4.1 Rising Prices and Lower Availability of Raw Materials in the Gelatin Industry

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Rising Demand for Empty Capsules in the Nutraceutical & Cosmetic Industries
6.2.2 Growing Demand & Adoption of Vegetarian Capsules
6.2.3 Increasing Collaborations Among Empty Capsule Manufacturers
6.3 Pharmaceutical Gelatin Market
6.4 Pricing Analysis
6.5 Regulatory Analysis

7 Empty Capsules Market, By Type
7.1 Introduction
7.2 Gelatin Capsules
7.2.1 Pig Meat Gelatin
7.2.2 Bovine-Derived Gelatin
7.2.3 Bone Meal
7.2.4 Other Gelatin Sources
7.3 Non-Gelatin Capsules
7.3.1 Hydroxypropyl Methylcellulose (HPMC)
7.3.2 Pullulan & Starch Material

8 Empty Capsules Market, By Functionality
8.1 Introduction
8.2 Immediate-Release Capsules
8.3 Sustained-Release Capsules
8.4 Delayed-Release Capsules

9 Empty Capsules Market, By Application
9.1 Introduction
9.2 Antibiotic & Antibacterial Drugs
9.3 Dietary Supplements
9.4 Antacid & Antiflatulent Preparations
9.5 Antianemic Preparations
9.6 Anti-Inflammatory Drugs
9.7 Cardiovascular Therapy Drugs
9.8 Cough & Cold Drugs
9.9 Other Applications

10 Empty Capsules Market, By End User
10.1 Introduction
10.2 Pharmaceutical Industry
10.3 Nutraceutical Industry
10.4 Cosmetic Industry
10.5 Research Laboratories

11 Empty Capsules Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Latin America
11.6 Middle East & Africa

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product Launches
12.3.2 Expansions
12.3.3 Acquisitions
12.3.4 Other Strategies

13 Company Profiles
13.1 Capsugel
13.2 Acg Worldwide
13.3 Qualicaps
13.4 Suheung Co., Ltd.
13.5 Capscanada Corporation
13.6 Qingdao Yiqing Medicinal Capsules Co., Ltd.
13.7 Shanxi Guangsheng Medicinal Capsules Co., Ltd.
13.8 Healthcaps India Ltd.
13.9 Snail Pharma Industry Co. Ltd.
13.10 Roxlor
13.11 Sunil Healthcare Ltd.
13.12 Medi-Caps Ltd.
13.13 Nectar Lifesciences Ltd.
13.14 Natural Capsules Limited
13.15 Bright Pharma Caps Inc.

For more information about this report visit https://www.researchandmarkets.com/research/7zfrv3/empty_capsules?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.


            

Contact Data